Entheon Biomedical Inc.

Private Company

Company Overview

Entheon Biomedical Inc. is a biotechnology company committed to the development of safe and effective psychedelic medicines in order to provide patients with access to evidence-based treatments for addiction disorders.

The company is researching patented psilocybin-based and DMT-based formulations for products for the treatment of addiction disorders. Beginning with animal toxicology and behavioral studies, the company plans to follow the strict regulatory pathways of classic drug discovery and approval before moving into human clinical trials and commercialization.

Management Team

Timothy Ko
Chief Executive Officer

Brandon Schwabe
Chief Financial Officer

Andrew Hegle, Ph.D.
Director or Operations

Christopher Gondi, Ph.D., M.Sc.
Chief Scientific Officer

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.